These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 36102413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
    Coelho RA, Joffe LS, Alves GM, Figueiredo-Carvalho MHG, Brito-Santos F, Amaral ACF, Rodrigues ML, Almeida-Paes R.
    PLoS One; 2020; 15(5):e0229630. PubMed ID: 32401759
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Chromoblastomycosis caused by Fonsecaea: clinicopathology, susceptibility and molecular identification of seven consecutive cases in Southern China.
    Yang YP, Li W, Huang WM, Zhou Y, Fan YM.
    Clin Microbiol Infect; 2013 Nov; 19(11):1023-8. PubMed ID: 23153454
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
    Hu Y, Huang X, Lu S, Hamblin MR, Mylonakis E, Zhang J, Xi L.
    Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro interaction of terbinafine with itraconazole and amphotericin B against fungi causing chromoblastomycosis in China.
    Yu J, Li R, Zhang M, Liu L, Wan Z.
    Med Mycol; 2008 Nov; 46(7):745-7. PubMed ID: 18608889
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela.
    Carolina Rojas O, León-Cachón RB, Pérez-Maya AA, Aguirre-Garza M, Moreno-Treviño MG, González GM.
    Mycoses; 2015 May; 58(5):267-72. PubMed ID: 25728464
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy combined with antifungal drugs against chromoblastomycosis and the effect of ALA-PDT on Fonsecaea in vitro.
    Hu Y, Qi X, Sun H, Lu Y, Hu Y, Chen X, Liu K, Yang Y, Mao Z, Wu Z, Zhou X.
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007849. PubMed ID: 31671098
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.
    Calvo E, Pastor FJ, Mayayo E, Hernández P, Guarro J.
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3709-13. PubMed ID: 21576429
    [Abstract] [Full Text] [Related]

  • 20. An impressive case of chromoblastomycosis due to Fonsecaea pedrosoi in a patient with a long history of fungal infection.
    Romero-Navarrete M, Ruíz LF, Castillo A, Arenas R, Vega-Memije ME, Xicohtencatl-Cortes J, Espinoza-Rivera M, Hernández-Castro R.
    J Mycol Med; 2018 Dec; 28(4):663-665. PubMed ID: 30126716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.